Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.06 +0.03 (+100.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nymox Pharmaceutical (NYMXF) Debt Ratio (2015 - 2021)

Updated

Nymox Pharmaceutical's (NYMXF) Debt Ratio came in at 0.12 for Q3 2021, up 151.1% from the prior quarter.

Analysis

Nymox Pharmaceutical (NYMXF) Debt Ratio (2015 - 2021) Analysis & Trends

For FY2020, Nymox Pharmaceutical's Debt Ratio stood at 0.08.

  • In prior years, Nymox Pharmaceutical's Debt Ratio was 0.00 in FY2019 and 0.45 in FY2016 (-60.4%).
  • Quarterly Debt Ratio has run from a low of 0.00 in Q4 2019 to a high of 0.45 in Q4 2016 over five years.
  • According to Business Quant data, Debt Ratio for the three prior quarters was 0.05 (Q2 2021), 0.23 (Q1 2021) and 0.08 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 0.39
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.23
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 0.52
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 0.42
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 0.08
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 0.28
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 0.53
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 0.31
10 Nymox Pharmaceutical 5.76 Mn 5.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 0.12
Jun 30, 2021 0.05
Mar 31, 2021 0.23
Dec 31, 2020 0.08
Dec 31, 2019 0.00
Dec 31, 2016 0.45
Dec 31, 2015 1.14
API Access

Nymox Pharmaceutical Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=NYMXF&period=max&api_key=YOUR_API_KEY